We are proud to share that NNIT has received Veeva partner acknowledgement for Veeva Post-Implementation for the following Vault applications: Vault QualityDocs, Vault Submissions, Vault eTMF, Vault QMS, and Vault CTMS.
We are delighted to announce that NNIT is a Veeva AI Partner, joining a group of select global partners.
Together with Astralis, we are currently exploring insights from game studies as an alternative to traditional e-learning for public IT systems, considering both the case handler and citizen perspectives.
Life science organizations face complex regulatory challenges, intensive audits, and robust internal process controls. With this new partnership, NNIT and Gimmal provide a well-established, compliant solution that customers operating within life sciences can rely on to manage the information lifecycle of GxP records.
In January 2024, NNIT became the first certified training partner for the OutSystems low-code platform in Denmark. This important achievement is in line with our strategic commitment to great educational experiences where we want to fully support the technological proficiency in the Danish region.
“With numerous successful training sessions already under our belt, NNIT is now positioned to ele
Having already partnered with IBM on the implementation of a finance-grade ESG system, NNIT now onboards sustainability experts Transition to provide end-to-end ESG advisory services.
We are delighted to announce that NNIT has authored new documentation on Dynamics 365 Guides in GxP regulated industries, which has just been published on learn.microsoft.com.
Together with their business partner Muninn, NNIT has won a new four-year contract with the Danish Health Data Authority for a network detection and response solution to be implemented across the entire Danish healthcare sector.
In 2020, NNIT became one of the first partners to be certified as a Premiere Services Partner for Veeva Development Cloud - the highest partner acknowledgement by Veeva. Now, NNIT has been recertified with the foremost partner accreditation once again.
“I am very proud of our accomplishments, and the recognitions are a testament to the hard work and dedication put in by our amazing team of cons
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product